Literature DB >> 17532064

A propensity-matched study of the association of physical function and outcomes in geriatric heart failure.

Ali Ahmed1, Wilbert S Aronow.   

Abstract

Most heart failure (HF) patients are older adults. However, the association of functional status and outcomes in ambulatory older adults with chronic HF has not been well studied. Of the 7788 Digitalis Investigation Group (DIG) trial participants, 4036 were > or =65 years. Of these, 1369 (34%) had New York Heart Association (NYHA) class III-IV symptoms. We calculated propensity scores for NYHA III-IV symptoms for all 4036 patients using a non-parsimonious logistic regression model. We used propensity scores to match 1010 (74% of 1369) NYHA III-IV patients with 1010 of NYHA I-II patients. Kaplan-Meier and matched Cox proportion hazard analyses were used to estimate associations of NYHA class III-IV with mortality and hospitalizations. Patients had a mean age of 73 years, 31% were female, and 11% were nonwhites. All-cause mortality occurred in 394 (rate, 1385/10000 person-years) NYHA I-II and 452 (rate, 1654/10000 person-years) NYHA III-IV patients, respectively, during 2967 and 2733 years of follow up (hazard ratio: {HR}, 1.28; 95% confidence interval {CI}, 1.09-1.50; p=0.002). NYHA III-IV class was associated with increased cardiovascular (HR, 1.25; 95% CI, 1.04-1.49; p=0.016) and HF mortality (HR, 1.51; 95% CI, 1.16-1.97; p=0.002). NYHA III-IV class was not significantly associated with hospitalizations due to all causes (HR, 1.10; 95% CI, 0.96-1.25; p=0.165), cardiovascular causes (HR, 1.11; 95% CI, 0.96-1.29; p=0.150), or worsening HF (HR, 1.09, 95% CI, 0.92-1.30; p=0.330). Baseline NYHA functional class was associated with mortality but not with hospitalization in ambulatory older adults with chronic HF.

Entities:  

Mesh:

Year:  2007        PMID: 17532064      PMCID: PMC2685164          DOI: 10.1016/j.archger.2007.03.010

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  20 in total

1.  Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.

Authors:  S T Normand; M B Landrum; E Guadagnoli; J Z Ayanian; T J Ryan; P D Cleary; B J McNeil
Journal:  J Clin Epidemiol       Date:  2001-04       Impact factor: 6.437

2.  A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.

Authors:  Peter C Austin; Paul Grootendorst; Geoffrey M Anderson
Journal:  Stat Med       Date:  2007-02-20       Impact factor: 2.373

3.  Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.

Authors:  Tamara B Horwich; Gregg C Fonarow; Michele A Hamilton; W Robb MacLellan; Jeff Borenstein
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

4.  Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.

Authors:  W Jiang; J Alexander; E Christopher; M Kuchibhatla; L H Gaulden; M S Cuffe; M A Blazing; C Davenport; R M Califf; R R Krishnan; C M O'Connor
Journal:  Arch Intern Med       Date:  2001 Aug 13-27

5.  Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods.

Authors:  Ali Ahmed; Ahsan Husain; Thomas E Love; Giovanni Gambassi; Louis J Dell'Italia; Gary S Francis; Mihai Gheorghiade; Richard M Allman; Sreelatha Meleth; Robert C Bourge
Journal:  Eur Heart J       Date:  2006-05-18       Impact factor: 29.983

6.  Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function.

Authors:  Ali Ahmed; Wilbert S Aronow; Jerome L Fleg
Journal:  Am Heart J       Date:  2006-02       Impact factor: 4.749

7.  A propensity matched study of New York Heart Association class and natural history end points in heart failure.

Authors:  Ali Ahmed
Journal:  Am J Cardiol       Date:  2006-12-28       Impact factor: 2.778

8.  Determination of vital status at the end of the DIG trial.

Authors:  Joseph F Collins; Cindy L Howell; R Anne Horney
Journal:  Control Clin Trials       Date:  2003-12

9.  One-year mortality among unselected outpatients with heart failure.

Authors:  J Muntwyler; G Abetel; C Gruner; F Follath
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

10.  Predicting mortality in patients with heart failure: a pragmatic approach.

Authors:  M L Bouvy; E R Heerdink; H G M Leufkens; A W Hoes
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

View more
  4 in total

1.  Association between smoking and outcomes in older adults with atrial fibrillation.

Authors:  Pushkar P Pawar; Linda G Jones; Margaret Feller; Jason L Guichard; Marjan Mujib; Mustafa I Ahmed; Brita Roy; Toufiqur Rahman; Inmaculada B Aban; Thomas E Love; Michel White; Wilbert S Aronow; Gregg C Fonarow; Ali Ahmed
Journal:  Arch Gerontol Geriatr       Date:  2011-07-06       Impact factor: 3.250

Review 2.  DEFEAT heart failure: assessment and management of heart failure in nursing homes made easy.

Authors:  Ali Ahmed; Linda Jones; Clare I Hays
Journal:  J Am Med Dir Assoc       Date:  2008-06-03       Impact factor: 4.669

3.  A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure.

Authors:  A Brent Alper; Ruth C Campbell; Stefan D Anker; George Bakris; Christy Wahle; Thomas E Love; L Lee Hamm; Marjan Mujib; Ali Ahmed
Journal:  Int J Cardiol       Date:  2008-08-08       Impact factor: 4.164

4.  A propensity-matched study of outcomes of chronic heart failure (HF) in younger and older adults.

Authors:  Christy Wahle; Chris Adamopoulos; O James Ekundayo; Marjan Mujib; Wilbert S Aronow; Ali Ahmed
Journal:  Arch Gerontol Geriatr       Date:  2008-08-09       Impact factor: 3.250

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.